Trial population
cholangiocarcinoma, gall bladder carcinoma
CHOLANGIOCARCINOMA, GALL BLADDER CARCINOMA
Patients with cholangiocarcinoma or gall bladder carcinoma after progressing on a gemcitabine based first-line therapy and fulfilling the other inclusion criteria will be eligible to participate in this clinical trial.